France plans 2nd COVID-19 booster dose for adults aged 18-59

France will offer a second COVID-19 booster jab to at-risk adults aged from 18 to 59

सम्बन्धित सामग्री

COVID-19 booster dose to children from today

KATHMANDU, June 10: The government is administering COVID-19 booster dose to children from Friday.  According to the Ministry of Health and Population (MoHP), children aged between 12 to 17 years will be inoculated with the dose from today. All children who received their second COVID-19 vaccine three months ago are eligible for the booster dose, according to an official at the Health Ministry. Children can visit health institutions or vaccine centers nearby to receive the vaccine.

France to start administering 4th COVID-19 vaccine dose

France will start offering on Monday a fourth COVID-19 vaccination shot to people over 80 years old who have received their booster dose.

Lalitpur to give booster dose from tomorrow

The Lalitpur Metropolitan City to give booster dose vaccine against COVID-19 from Tuesday.

Study: COVID-19 Omicron variant neutralized by booster dose

The new COVID-19 Omicron variant is more transmissible than the Delta variant.

Study: COVID-19 Omicron variant neutralized by booster dose

The new COVID-19 Omicron variant is more transmissible than the Delta variant.

COVID-19 booster dose to be provided to fully vaccinated senior citizens

KATHMANDU, December 9: The Ministry of Health and Population (MoHP) is to administer a booster dose of COVID-19 vaccine to senior citizens, who are already vaccinated with full-dose of the vaccine.  The Ministry, on the recommendation of the National Vaccine Advisory Committee, is going to provide a booster dose to senior citizens above 60 years.   Chief of the Family Welfare Division of Department of Health Services, Dr Bibek Kumar Lal, shared that senior citizens above 60 years and already vaccinated with full-dose of vero cell, have started getting booster dose.  At a regular press briefing organised at the Ministry on Wednesday, he said that the WHO has recommended administering a booster dose to those citizens, who have already received full-dose of vero cell vaccine and are above 60 years.  The Advisory Committee has recommended a booster dose to all the people above 60 years and vaccinated with full-dose of vero cell  after three months of receiving the vaccine in Nepal. RSS

What to Know About COVID-19 Vaccine Boosters

By Dr. Dave A. Chokshi Recently, important updates about the COVID-19 vaccine were announced—that certain people are now eligible for a “booster” dose. Since the beginning of COVID-19, our scientific understanding of the virus has constantly evolved, and many New Yorkers understandably have questions about this new development. I would like to provide the “who, […]

U.S. approves new booster of COVID-19 vaccines, "mix and match" dose

WASHINGTON, Oct. 20: The U.S. Food and Drug Administration (FDA) on Wednesday authorized COVID-19 booster doses of Moderna and Johnson & Johnson, and approved "mix and match" booster dose for currently available approved COVID-19 vaccines. The agency authorized the use of a single booster dose of the Moderna COVID-19 vaccine at least 6 months after completion of the primary shots to people 65 years of age and older, 18 through 64 years of age at high risk of severe COVID-19, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2. As for the Johnson & Johnson booster dose, the FDA authorized the use of a single booster dose at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older. A single booster dose of any of the available COVID-19 vaccines may be administered as a "mix and match" booster dose following completion of primary vaccination with a different available COVID-19 vaccine, according to the FDA. For instance, a person who got a Johnson & Johnson vaccine could receive one from Moderna or Pfizer-BioNTech as a booster. "The available data suggest waning immunity in some populations who are fully vaccinated," said Acting FDA Commissioner Janet Woodcock in a statement. "The availability of these authorized boosters is important for continued protection against COVID-19 disease." The decision came after an FDA advisory committee voted last week to recommend authorizing Moderna and Johnson & Johnson's COVID-19 booster doses. In September, the FDA authorized the first booster shots for the Pfizer-BioNTech COVID-19 vaccine, allowing a single booster dose of the Pfizer-BioNTech vaccine be administered at least 6 months after completion of the primary series to individuals 65 years of age and older, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2. A recent study of the "mix and match" approach funded by the U.S. National Institutes of Health found no safety concerns using different vaccines as a booster. The study found that people who received the Johnson & Johnson vaccine produced stronger antibody levels after they got booster shots made by Moderna or Pfizer-BioNTech, compared to boosters from Johnson & Johnson.